• Contact & Directions
  • Jobs
  • KiTZ Programs
  • In Emergencies
  • de
  • En
Hopp Children's Cancer Center Heidelberg
  • For Patients
  • For Physicians
  • Research
  • The KiTZ
  • Donation
  • Contact & Directions
  • Jobs
  • KiTZ Programs
  • In Emergencies
  •  
  • For Patients
    • Treatment
      • Leukemia and Lymphomas
      • CNS / brain tumors
      • Sarcomas
      • Embryonal tumors
      • Hereditary cancers
      • Rare Tumors
      • Non-malignant Blood Diseases
        • Thalassemia and sickle cell anemia center
        • Gene therapy thalassemia
    • Second opinions
    • Relapse patients
    • Hospital team
      • Our physicians
        • Our consultants
        • Specialists and physicians i. sp. t.
      • Psychosocial team
      • KiTZ nursing team
    • Counseling & Support
      • Psycho-social care
      • Hospital school
      • Kinderplanet
      • Parent accomodation
    • Studies at the KiTZ
    • Our sponsors
  • For Physicians
    • Treatment
      • Leukemia and Lymphomas
      • CNS / brain tumors
      • Sarcomas
      • Embryonal tumors
      • Hereditary cancers
      • Rare tumors
      • Non-malignant blood disorders
        • Thalassemia and sickle cell disease center
    • Second opinions
    • Relapse patients
    • Hospital Team
      • Nursing team
    • Counseling & support
      • Psycho-social care
      • The Heidelberg Hospital School
      • Kinderplanet: The Children's planet
      • Parent accomodation
    • Clinical studies
      • KiTZ Clinical Trial Unit
        • Translational Trial Group
      • Molecular Diagnostics Studies
        • INFORM
        • PTT 2.0
        • MNP 2.0
        • MNP Int R
        • LOGGIC Core
      • Phase-I and II studies
        • INFORM2-NivEnt
        • Larotrectinib (LOXO-101)
        • Dabrafenib/Trametinib
        • iVAC-ALL
        • OSCAR
        • Selpercatinib
        • Olaparib
      • Phase-III studies
      • Registry
        • Sickle cell registry
        • registry rare anaemias
    • Our sponsors
  • Research
    • Research groups
      • Hematology
        • Group Leukemia
        • Group Iron metabolism
        • Group mRNA metabolism
        • Group Anemia
      • CNS / brain tumors
        • JRG Dev. Origins
        • Group Clinical bioinformatics
        • JRG Ped. glioma research
        • Group Functional Studies
        • Group Preclinical research
        • Group Trans. brain tumor modeling
        • Group Early cancer diagnostics
        • Group Preclinical Modeling
      • Sarcoma
        • Transl. Ped. Sarcoma Research
        • Group Soft-tissue sarcoma
        • Group Osteosarcoma
      • Embryonic tumors
        • Group Neuroblastoma
      • Hereditary cancers
        • Group Early cancer diagnostics
      • Rare tumors
      • Translational Trial Group
    • Research projects
      • ITCCP4
      • Everest
      • INFORM
      • PTT 2.0
      • MNP 2.0
      • MNP Int-R
    • Research cooperations
      • KKE Neuropathologie
      • CCU Pediatric Oncology
      • Molecular Genetics
      • ITCC
      • Cancer predisposition
      • MMPU
      • ICGC PedBrain
    • Datacommons
      • PedPanCan
    • Our Sponsors
  • The KiTZ
    • Figures and Facts
    • KiTZ Programs
    • KiTZ directorate
    • DKFZ
    • UKHD
    • Uni HD
    • NCT
    • The KiTZ building
    • Our Sponsors
    • Our ambassadors
    • KiTZ Newsroom
      • KiTZ News
      • Press releases
      • KiTZ Stories
        • Stories archive
      • Events
    • Jobs
    • Contacts
    • Directions
  • Donation
    • KiTZ products
  • Data privacy protection
  • Accessibility
  • Imprint
  • Contact
  • Deutsch
Overview For Patients
Treatment
  • Leukemia and Lymphomas
  • CNS / brain tumors
  • Sarcomas
  • Embryonal tumors
  • Hereditary cancers
  • Rare Tumors
  • Non-malignant Blood Diseases
Second opinions
Relapse patients
Hospital team
  • Our physicians
  • Psychosocial team
  • KiTZ nursing team
Counseling & Support
  • Psycho-social care
  • Hospital school
  • Kinderplanet
  • Parent accomodation
Studies at the KiTZ
Our sponsors
Overview For Physicians
Treatment
  • Leukemia and Lymphomas
  • CNS / brain tumors
  • Sarcomas
  • Embryonal tumors
  • Hereditary cancers
  • Rare tumors
  • Non-malignant blood disorders
Second opinions
Relapse patients
Hospital Team
  • Nursing team
Counseling & support
  • Psycho-social care
  • The Heidelberg Hospital School
  • Kinderplanet: The Children's planet
  • Parent accomodation
Clinical studies
  • KiTZ Clinical Trial Unit
  • Molecular Diagnostics Studies
  • Phase-I and II studies
  • Phase-III studies
  • Registry
Our sponsors
Overview Research
Research groups
  • Hematology
  • CNS / brain tumors
  • Sarcoma
  • Embryonic tumors
  • Hereditary cancers
  • Rare tumors
  • Translational Trial Group
Research projects
  • ITCCP4
  • Everest
  • INFORM
  • PTT 2.0
  • MNP 2.0
  • MNP Int-R
Research cooperations
  • KKE Neuropathologie
  • CCU Pediatric Oncology
  • Molecular Genetics
  • ITCC
  • Cancer predisposition
  • MMPU
  • ICGC PedBrain
Datacommons
  • PedPanCan
Our Sponsors
Overview The KiTZ
Figures and Facts
KiTZ Programs
KiTZ directorate
DKFZ
UKHD
Uni HD
NCT
The KiTZ building
Our Sponsors
Our ambassadors
KiTZ Newsroom
  • KiTZ News
  • Press releases
  • KiTZ Stories
  • Events
Jobs
Contacts
Directions
Overview Donation
KiTZ products
  • Hopp Children's Cancer Center Heidelberg
  • For Physicians
  • Clinical studies
  • Registry
  • Treatment
    • Leukemia and Lymphomas
    • CNS / brain tumors
    • Sarcomas
    • Embryonal tumors
    • Hereditary cancers
    • Rare tumors
    • Non-malignant blood disorders
      • Thalassemia and sickle cell disease center
  • Second opinions
  • Relapse patients
  • Hospital Team
    • Nursing team
  • Counseling & support
    • Psycho-social care
    • The Heidelberg Hospital School
    • Kinderplanet: The Children's planet
    • Parent accomodation
  • Clinical studies
    • KiTZ Clinical Trial Unit
      • Translational Trial Group
    • Molecular Diagnostics Studies
      • INFORM
      • PTT 2.0
      • MNP 2.0
      • MNP Int R
      • LOGGIC Core
    • Phase-I and II studies
      • INFORM2-NivEnt
      • Larotrectinib (LOXO-101)
      • Dabrafenib/Trametinib
      • iVAC-ALL
      • OSCAR
      • Selpercatinib
      • Olaparib
    • Phase-III studies
    • Registry
      • Sickle cell registry
      • registry rare anaemias
  • Our sponsors

Registry for cancer and blood diseases

To better supply patients with oncological and hematological diseases, the GPOH created platforms to collect data on the disease itself, potential treatment options, as well as complications, and provides it for scientific analysis.

Oncology-Registry

  • Overview of the GPOH Oncology-Registry

Hematology-Registry

  • Sickle cell registry
  • Registry for rare anaemias
  • Overview of the GPOH Hematology-Registry (Link only in German)
KiTZ Supporting Institutions:German Cancer Research CenterHeidelberg University HospitalHeidelberg University
  • Sitemap
  • Data privacy protection
  • Accessibility
  • Imprint
  • Contact
de
This website uses cookies. By continuing to us the Site, you agree to the use of cookies Privacy Information. I accept.